The world’s biggest pharmaceutical firms are little prepared for the next pandemic despite a mounting response to the Covid-19 outbreak, an independent report has warned.
Jayasree K Iyer, executive director of the Netherlands-based Access to Medicine Foundation, a not-for-profit organisation funded by the UK and Dutch governments and others, highlighted an outbreak of the Nipah virus in China, with a fatality rate of up to 75%, as potentially the next big pandemic risk.
“Nipah virus is another emerging infectious disease that causes great concern,” she said. “Nipah could blow any moment. The next pandemic could be a drug-resistant infection.”
Nipah can cause severe respiratory problems and encephalitis, swelling of the brain, and has a mortality rate of 40% to 75%, depending on where the outbreak occurs. Fruit bats are its natural host. Outbreaks in Bangladesh and India were probably linked to drinking date palm juice.
It is one of 10 infectious diseases out of 16 identified by the World Health Organization as the greatest public health risk where there are zero projects in pharmaceutical firms’ pipelines, according to the foundation’s biennial report. […]
This is the 4th pandemic I have participated in. AIDS, Lyme, Ebola and COVID SARS-2. The next one within say 10 years is inevitable and governments are totally unprepared. Philip Askenase, Yale Medial School,
We need to take at least half of the money we spend on the “war machine” and put it to better use: fostering wellbeing.